RxDoctor Payments Data

Sadia Arshad, MD

Rheumatology · Howard Beach, NYNPI 1841422516

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Penumbra, Inc. accounts for 83.6% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for rheumatology clinicians in NY, where the typical reported total is $1,764.

$148in general payments, 2019–2025

Across 2 payments — averaging $73.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$123
  • GSK$24

What the payments were for

  • Food & beverage$148100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Penumbra, Inc.1$123
GSK1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$148 in reported general payments places this provider in the 20th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York →

Medicare billing

Part B allowed, 2024
$368,522
Medicare patients
156
Services billed
15,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab33$220,500
Enbrel SureclickEtanercept14$202,893
Humira PenAdalimumab12$76,625
ProliaDenosumab11$18,438
Azathioprine63$6,757
Leflunomide77$5,405
Hydroxychloroquine Sulfate232$5,367
Diclofenac Sodium108$4,124
MethotrexateMethotrexate Sodium125$1,929
Duloxetine Hcl39$1,398
Gabapentin115$1,155
Sulfasalazine68$1,090
Alendronate Sodium138$562
Febuxostat17$546
Clobetasol Propionate15$486

Paid to pharmacies, not to this prescriber.

Other rheumatology in Howard Beach

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →